Application of luteinizing hormone-releasing hormone–ferrosoferric oxide nanoparticles in targeted imaging of breast tumors

BACKGROUND: Ferrosoferric oxide (Fe(3)O(4)) nanoparticles are a commonly used magnetic resonance imaging (MRI) reagent. Luteinizing hormone-releasing hormone (LHRH) is highly expressed on the surfaces of tumors, but its expression is low or absent in the corresponding normal tissues, allowing it to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nian, Di, Shi, Peng, Sun, Junjie, Ren, Li, Hao, Xiaona, Han, Junwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Pre-Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460613/
https://www.ncbi.nlm.nih.gov/pubmed/30880516
http://dx.doi.org/10.1177/0300060519834457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460613/
https://www.ncbi.nlm.nih.gov/pubmed/30880516
http://dx.doi.org/10.1177/0300060519834457

Ejemplares similares